

Reduction of bacterial endotoxin
Depyrogenated RTU components address the needs of the parenteral market, by ensuring the delivery of endotoxin free components meeting USP <85> and EP 2.6.14 reduction of pyrogenic substances, including bacterial endotoxin standards to achieve endotoxin levels meeting acceptable limits. Minimizing time-consuming upstream processing steps required of Pharmaceutical Drug Manufacturers.
Parenteral drug products must be manufactured to strict sterility guidelines using well documented and validated aseptic processes. To meet this need, DWK provides our Customers with glass vials prepared using validated processes that ensure the removal of bacterial endotoxins to acceptable endotoxin limits (0.25 EU/ml) . Each glass vial is subjected to high dry heat treatment to destroy pyrogens and vacuum packaged within an ISO clean room environment for terminal sterilization.